Organization
Juravinski Cancer Inst
4 abstracts
Abstract
Artemin and immune checkpoint inhibitor (ICI) efficacy in metastatic colorectal cancer (mCRC): A correlative analysis of the Canadian Cancer Trials Group (CCTG) CO.26 trial.Org: Princess Margaret Cancer Centre, University Health Network, Genome Sciences Centre, BCCA, The Ottawa Hospital Cancer Centre, Oregon Health & Science University,
Abstract
A phase II study of durvalumab re-treatment +/- prednisone in patients who discontinued prior checkpoint therapy due to immune related toxicity (CCTG IND.238A).Org: Juravinski Cancer Inst, BCCA, Sindi Ahluwalia Hawkins Centre for the Southern Interior, Princess Margaret - University Health Network, Juravinski Cancer Centre, McMaster University,
Abstract
Plasma arginine as a candidate predictive biomarker for response to immune checkpoint inhibition (ICI) in metastatic colorectal cancer (mCRC): Analysis of the CCTG CO.26 trial.Org: University Health Network, BCCA Vancouver Cancer Centre, The Ottawa Hospital Cancer Centre, Providence Cancer Institute, Queen's University, Belfast,
Abstract
Use of antibiotics and outcomes of patients presenting to emergency department with non-neutropenic fever and/or suspected infection.Org: Juravinski Hospital and Cancer Centre, Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy, Juravinski Cancer Centre, Michael G. DeGroote School of Medicine, Juravinski Cancer Inst,